AML-632: Revumenib Therapy Post Hematopoietic Stem Cell Transplant for Patients With Relapsed/Refractory KMT2Ar, NPM1m, and NUP98r Acute Myeloid Leukemia: Post Hoc Analysis of Outcomes From AUGMENT-101

Poster Presentation | Sep 9, 2026

Author

Issa GC, et al.

Congress

Society of Hematologic Oncology (SOHO) 14th Annual Meeting

Houston, Texas | Sep 9 – 12, 2026